STOCK TITAN

ELITE HEALTH SYSTEMS 10-Q Filings

EHSI OTC

Every 10-Q that ELITE HEALTH SYSTEMS (EHSI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow EHSI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EHSI filings page.

Rhea-AI Summary

Elite Health Systems Inc. (EHSI) reported its first meaningful operating revenues as it launched Medicare Advantage plans and consolidated Physician Support Systems (PSS), but results remain deeply loss-making with liquidity pressure. For the six months ended June 30, 2026, revenue was $2.7 million (all from services and policy revenue, versus zero a year earlier), while the net loss widened to $2.8 million from $0.9 million.

Total assets fell to $3.9 million from $6.7 million at December 31, 2025, and cash declined to $1.3 million from $3.8 million. Working capital dropped to $0.5 million, and accumulated deficit increased to $15.1 million. Management states that these factors raised substantial doubt about the company’s ability to continue as a going concern, although it points to roughly $14 million previously raised and believes additional capital is accessible.

The board has authorized a strategic review that may include new equity or debt, asset sales, or a merger or disposition of all assets, with no set timetable. After quarter-end, EHSI entered into a $525,000 subordinated note with its CEO at 10% interest, paired with warrants for 110,526 shares at $0.95, and may accept up to $1.5 million on the same terms.

Rhea-AI Summary

Elite Health Systems Inc. reported a larger loss as it ramped up its new Medicare Advantage and healthcare services platform in the quarter ended March 31, 2026. Revenue was $1.4 million, primarily from related-party services at Physician Support Systems, while net loss widened to $1.3 million from $0.4 million a year earlier.

Total assets fell to $5.4 million, including cash of $2.6 million, and stockholders’ equity declined to $4.1 million as the accumulated deficit reached $13.5 million. Management disclosed that recurring losses, limited cash and no credit facility raised substantial doubt about the company’s ability to continue as a going concern, though it has raised about $14 million in equity to date and expects to seek more capital in 2026.

Elite Health has obtained a Knox-Keene license and Centers for Medicare & Medicaid Services approval to operate Medicare Advantage plans in several California counties and began plan operations on January 1, 2026. It also completed the acquisition of Physician Support Systems, Inc. in late 2025, recording goodwill of $4.96 million and later recognizing a $3.98 million goodwill impairment.

Rhea-AI Summary

Elite Health Systems Inc. (EHSI) reported a wider quarterly loss as it builds its Medicare Advantage platform. For Q3 2025, the company recorded no revenue and a net loss of $1,161,000 versus $290,000 a year ago, driven by higher selling, general and administrative expenses of $1,165,000 (up from $387,000).

Cash and cash equivalents were $3,970,000, total stockholders’ equity was $5,020,000, and 21,939,924 common shares were outstanding as of October 31, 2025. Year‑to‑date, the net loss was $2,026,000 versus $1,034,000 in 2024. The company raised $5,825,000 earlier in 2025 and an additional $1,890,000 by September 30, 2025 at $0.95 per share, exceeding $3,000,000 by the filing date.

Elite Health received a Knox‑Keene license in May 2025 and CMS conditional approval in June 2025, began marketing in October 2025, and plans to begin providing services on January 1, 2026. Stockholders approved issuing 3,158,000 shares to acquire Physician Support Systems, Inc., which closed November 1, 2025. The filing notes substantial doubt about going concern at September 30, 2025, though management cites recent financings and plans to continue operations.